Review
Recent Advances on the Pathogenesis of Huntington's Disease

https://doi.org/10.1006/exnr.1998.7006Get rights and content

Abstract

We review recent advances regarding the pathogenesis of Huntington's disease (HD). This genetic neurodegenerative disorder is caused by an expanded CAG repeat in a gene coding for a protein, with unknown function, called huntingtin. There is selective death of striatal and cortical neurons. Both in patients and a transgenic mouse model of the disease, neuronal intranuclear inclusions, immunoreactive for huntingtin and ubiquitin, develop. Huntingtin interacts with the proteins GAPDH, HAP-1, HIP1, HIP2, and calmodulin, and a mutant huntingtin is specifically cleaved by the proapoptotic enzyme caspase 3. The pathogenetic mechanism is not known, but it is presumed that there is a toxic gain of function of the mutant huntingtin. Circumstantial evidence suggests that excitotoxicity, oxidative stress, impaired energy metabolism, and apoptosis play a role.

References (169)

  • R.L. Albin et al.

    Genetics and molecular biology of Huntington's disease

    Trends Neurosci.

    (1995)
  • T. Alexi et al.

    3-Nitroproprionic acid's lethal triplet: Cooperative pathways of neurodegeneration

    Neuroreport

    (1998)
  • C.M. Ambrose et al.

    Structure and expression of the Huntington's disease gene: Evidence against simple inactivation due to an expanded CAG repeat

    Somat. Cell Mol. Genet.

    (1994)
  • M.A. Andrade et al.

    HEAT repeats in the Huntington's disease protein

    Nature Genet.

    (1995)
  • S.E. Andrew et al.

    The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

    Nature Genet.

    (1993)
  • M. Ankarcrona et al.

    Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function

    Neuron

    (1995)
  • M. Ankarcrona et al.

    Calcineurin and mitochondrial function in glutamate induced neuronal apoptosis

    FEBS Lett.

    (1996)
  • N. Aronin et al.

    CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain

    Neuron

    (1995)
  • T. Arzberger et al.

    Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease-An in situ hybridization study

    J. Neuropathol. Exp. Neurol.

    (1997)
  • T. Ashizawa et al.

    CAG repeat size and clinical presentation in Huntington's disease

    Neurology

    (1994)
  • S.J. Augood et al.

    Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease

    Ann. Neurol.

    (1997)
  • J. Bao et al.

    Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin

    Proc. Natl. Acad. Sci. USA

    (1996)
  • M.F. Beal et al.

    Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

    Nature

    (1986)
  • M.F. Beal et al.

    Chronic quinolinic acid lesions in rats closely resemble Huntington's disease

    J. Neurosci.

    (1989)
  • M.F. Beal

    Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses

    Ann. Neurol.

    (1992)
  • M.F. Beal et al.

    Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate

    J. Neurochem.

    (1993)
  • M.F. Beal et al.

    Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases

    Trends Neurosci.

    (1993)
  • M.F. Beal

    Aging, energy and oxidative stress in neurodegenerative diseases

    Ann. Neurol.

    (1995)
  • M.W. Becher et al.

    Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions andIT15

    Neurobiol. Dis.

    (1998)
  • M.I. Behrens et al.

    3-nitroproprionic acid induces apoptosis in cultured striatal and cortical neurons

    Neuroreport

    (1995)
  • J. Block-Galarza et al.

    Fast transport and retrograde movement of huntingtin and HAP1 in axons

    Neuroreport

    (1997)
  • G.Th.A.M. Bots et al.

    Neuropathological changes of the nucleus accumbens in Huntington's chorea

    Acta Neuropathol.

    (1987)
  • J. Brandt et al.

    Trinucleotide repeat length and clinical progression in Huntington's disease

    Neurology

    (1996)
  • D.E. Bredesen

    Neural apoptosis

    Ann. Neurol.

    (1995)
  • D.S. Bredt et al.

    Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase

    Neuron

    (1991)
  • J.R. Burke et al.

    Huntingtin and DRPLA proteins selectively interact with the enzyme GADPH

    Nature Med.

    (1996)
  • N.J. Butterworth et al.

    Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum

    Neuroscience

    (1998)
  • S. Cammarata et al.

    Ubiquitin-reactive neurites in cerebral cortex of subjects with Huntington's chorea: A pathological correlate of dementia

    Neurosci. Lett.

    (1993)
  • L. Cariello et al.

    Transglutaminase activity is related to CAG repeat length in patients with Huntington's disease

    Hum. Genet.

    (1996)
  • J.H. Cha et al.

    Altered brain neurotransmittor receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene

    Proc. Natl. Acad. Sci. USA

    (1998)
  • K.O. Chase et al.

    Neuroanatomical features of a transgenic model of Huntington's disease

    Soc. Neurosci. Abstr.

    (1998)
  • S. Claes et al.

    Correlations between triplet repeat expansion and clinical features in Huntington's disease

    Arch. Neurol.

    (1995)
  • V. Colomer et al.

    Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain

    Hum. Mol. Genet.

    (1997)
  • J.T. Coyle et al.

    Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea

    Nature

    (1976)
  • J.T. Coyle et al.

    Oxidative stress, glutamate, and neurodegenerative disorders

    Science

    (1993)
  • S.W. Davies et al.

    Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

    Cell

    (1997)
  • S.W. Davies et al.

    Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions

    Lancet

    (1998)
  • T.M. Dawson et al.

    Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissue

    Proc. Natl. Acad. Sci. USA

    (1991)
  • V.L. Dawson et al.

    Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures

    J. Neurosci.

    (1993)
  • V.L. Dawson et al.

    Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice

    J. Neurosci.

    (1996)
  • K.E. De Rooij et al.

    Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation

    Hum. Mol. Genet.

    (1996)
  • D.W. Dickson

    Apoptosis in the brain

    Am. J. Pathol.

    (1995)
  • M. DiFiglia et al.

    Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons

    Neuron

    (1995)
  • M. DiFiglia et al.

    Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

    Science

    (1997)
  • S. DiMauro et al.

    Mitochondrial DNA and diseases of the nervous system: The spectrum

    Neuroscientist

    (1998)
  • A. Doble

    Excitatory amino acid receptors and neurodegeneration

    Therapie

    (1995)
  • L.L. Dugan et al.

    Mitochondrial production of reactive oxygen species in cortical nertons following exposure toNd

    J. Neurosci.

    (1995)
  • M.P. Duyao et al.

    Inactivation of the mouse Huntington's disease gene homologHdh

    Science

    (1995)
  • M. Dragunow et al.

    In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes

    Neuroreport

    (1995)
  • S. Engelender et al.

    Huntingtin-associated protein 1 (HAP1) interacts with the p150 Glued subunit of dynactin

    Hum. Mol. Genet.

    (1997)
  • Cited by (132)

    • The protective role of exercise against age-related neurodegeneration

      2022, Ageing Research Reviews
      Citation Excerpt :

      It is also possible that endurance exercise improves HD phenotypes in mice in a non-mutually exclusive manner by directly reducing hyperactive cell death. Inappropriate activation of apoptosis may contribute to HD progression, and in vitro studies linked apoptosis and mHTT protein (Hickey and Chesselet, 2003; Petersen et al., 1999). In an HD mouse model in which the NMDA receptor agonist, quinolinic acid is injected intrastriatally to induce excitotoxicity (Bruyn and Stoof, 1990), 14 days of treadmill exercise increased anti-apoptotic BCL2 protein expression in hippocampus and decreased expression of the apoptotic indicators caspase-3 and BAX relative to unexercised HD controls.

    View all citing articles on Scopus

    P. Harper

    View full text